HIV-Specific Reported Outcome Measures: Systematic Review of Psychometric Properties

Overview

Journal JMIR Public Health Surveill

Publisher JMIR Publications

Date 2022 Oct 12

PMID 36222289

Authors

Ziqi Wang

Yaxin Zhu

Xiyu Duan

Hao Kang

Bo Qu

Affiliations

Soon will be listed here.

Abstract

Background: The management of people living with HIV and AIDS is multidimensional and complex. Using patient-reported outcome measures (PROMs) has been increasingly recognized to be the key factor for providing patient-centered health care to meet the lifelong needs of people living with HIV and AIDS from diagnosis to death. However, there is currently no consensus on a PROM recommended for health care providers and researchers to assess health outcomes in people living with HIV and AIDS.

Objective: The purpose of this systematic review was to summarize and categorize the available validated HIV-specific PROMs in adults living with HIV and AIDS and to assess these PROMs using the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) methodology.

Methods: This systematic review followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A literature search of 3 recommended databases (PubMed, Embase, and PsychINFO) was conducted on January 15, 2021. Studies were included if they assessed any psychometric property of HIV-specific PROMs in adults living with HIV and AIDS and met the eligibility criteria. The PROMs were assessed for 9 psychometric properties, evaluated in each included study following the COSMIN methodology by assessing the following: the methodological quality assessed using the COSMIN risk of bias checklist; overall rating of results; level of evidence assessed using the modified Grading of Recommendations, Assessment, Development, and Evaluation approach; and level of recommendation.

Results: A total of 88 PROMs classified into 8 categories, assessing the psychometric properties of PROMs for adults living with HIV and AIDS, were identified in 152 studies including 79,213 people living with HIV and AIDS. The psychometric properties of most included PROMs were rated with insufficient evidence. The PROMs that received class A recommendation were the Poz Quality of Life, HIV Symptom Index or Symptoms Distress Module of the Adult AIDS Clinical Trial Group, and People Living with HIV Resilience Scale. In addition, because of a lack of evidence, recommendations regarding use could not be made for most of the remaining assessed PROMs (received class B recommendation).

Conclusions: This systematic review recommends 3 PROMs to assess health outcomes in adults living with HIV and AIDS. However, all these PROMs have some shortcomings. In addition, most of the included PROMs do not have sufficient evidence for assessing their psychometric properties and require a more comprehensive validation of the psychometric properties in the future to provide more scientific evidence. Thus, our findings may provide a reference for the selection of high-quality HIV-specific PROMs by health care providers and researchers for clinical practice and research.

Citing Articles

Cannabis Use and Self-Reported Bothersome Symptoms in People with HIV.

Wrona A, Justice A, Tate J, Rentsch C, Gordon K, Kidwai-Khan F Cannabis. 2025; 8(1):177-190.

PMID: 39968492 PMC: 11831903. DOI: 10.26828/cannabis/2025/000269.

Development of a core patient-reported outcome set for use in HIV care at the individual patient level in Montreal: protocol for a two-phased multimethod project.

Engler K, Lessard D, Lacombe K, Palich R, Lebouche B BMJ Open. 2025; 15(1):e088822.

PMID: 39819929 PMC: 11751937. DOI: 10.1136/bmjopen-2024-088822.

Psychometric characteristics of the Spanish version of the HIV Symptom Index.

Ibarra-Barrueta O, Mora-Atorrasagasti O, Palacios-Zabalza I, Aguirre-Larracoechea U, Legarreta M, Gonzalez-Hernandez N J Patient Rep Outcomes. 2024; 8(1):116.

PMID: 39352593 PMC: 11445215. DOI: 10.1186/s41687-024-00780-2.

Structural Racism Conceptualization and Operationalization for Research for the U.S. HIV Epidemic: Findings from a Scoping Review and Implications for Advancing Research for Structural Interventions.

Muno B, Islam J, Schwartz R, Wallace S, Camacho-Rivera M, Patel R AIDS Behav. 2024; 28(Suppl 1):149-165.

PMID: 39093355 DOI: 10.1007/s10461-024-04417-9.

A qualitative study to identify thematic areas for HIV related patient-reported outcome measures (PROM) and patient-reported experience measures (PREM).

Lohiniva A, Isosomppi S, Pasanen S, Sutinen J J Patient Rep Outcomes. 2023; 7(1):41.

PMID: 37126134 PMC: 10151440. DOI: 10.1186/s41687-023-00582-y.

References

Golub S, Rendina H, Gamarel K . Identity-related growth and loss in a sample of HIV-positive gay and bisexual men: initial scale development and psychometric evaluation. AIDS Behav. 2012; 17(2):748-59. PMC: 3562368. DOI: 10.1007/s10461-012-0338-3. View

Kemmler G, Schmied B, Shetty-Lee A, Zangerle R, Hinterhuber H, Schussler G . Quality of life of HIV-infected patients: psychometric properties and validation of the German version of the MQOL-HIV. Qual Life Res. 2003; 12(8):1037-50. DOI: 10.1023/a:1026114004548. View

Lubeck D, Fries J . Assessment of quality of life in early stage HIV-infected persons: data from the AIDS Time-oriented Health Outcome Study (ATHOS). Qual Life Res. 1997; 6(6):494-506. DOI: 10.1023/a:1018404014821. View

Audet C, Wagner L, Wallston K . Finding meaning in life while living with HIV: validation of a novel HIV meaningfulness scale among HIV-infected participants living in Tennessee. BMC Psychol. 2015; 3(1):15. PMC: 4419455. DOI: 10.1186/s40359-015-0070-7. View

de Vet H, Terwee C . The minimal detectable change should not replace the minimal important difference. J Clin Epidemiol. 2010; 63(7):804-5. DOI: 10.1016/j.jclinepi.2009.12.015. View

Whalen C, Antani M, Carey J, Landefeld C . An index of symptoms for infection with human immunodeficiency virus: reliability and validity. J Clin Epidemiol. 1994; 47(5):537-46. DOI: 10.1016/0895-4356(94)90300-x. View

Bucciardini R, Murri R, Guarinieri M, Starace F, Martini M, Vatrella A . ISSQoL: a new questionnaire for evaluating the quality of life of people living with HIV in the HAART era. Qual Life Res. 2006; 15(3):377-90. DOI: 10.1007/s11136-005-3212-1. View

Lenderking W, Testa M, Katzenstein D, Hammer S . Measuring quality of life in early HIV disease: the modular approach. Qual Life Res. 1997; 6(6):515-30. DOI: 10.1023/a:1018408115729. View

Olsen M, Jensen N, Tesfaye M, Holm L . Conceptual equivalence of WHOQOL-HIV among people living with HIV in Ethiopia. Qual Life Res. 2012; 22(2):361-7. DOI: 10.1007/s11136-012-0141-7. View

10.

Jerant A, Tancredi D, Franks P . Mortality prediction by quality-adjusted life year compatible health measures: findings in a nationally representative US sample. Med Care. 2011; 49(5):443-50. DOI: 10.1097/MLR.0b013e318206c231. View

11.

Webb D, Horne R, Pinching A . Treatment-related empowerment: preliminary evaluation of a new measure in patients with advanced HIV disease. Int J STD AIDS. 2001; 12(2):103-7. DOI: 10.1258/0956462011916875. View

12.

Mathews W, McCutchan J, Asch S, Turner B, Gifford A, Kuromiya K . National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study. Med Care. 2000; 38(7):750-62. DOI: 10.1097/00005650-200007000-00007. View

13.

Wen H, Yang Z, Zhu Z, Han S, Zhang L, Hu Y . Psychometric properties of self-reported measures of health-related quality of life in people living with HIV: a systematic review. Health Qual Life Outcomes. 2022; 20(1):5. PMC: 8744327. DOI: 10.1186/s12955-021-01910-w. View

14.

Lee D, Patel P, Sachs J, Basinger S, Mathews W, Barber R . Psychometric properties of a lipodystrophy scale. AIDS Patient Care STDS. 2006; 20(1):30-5. DOI: 10.1089/apc.2006.20.30. View

15.

Holzemer W, Henry S, Nokes K, Corless I, Brown M, Powell-Cope G . Validation of the Sign and Symptom Check-List for Persons with HIV Disease (SSC-HIV). J Adv Nurs. 1999; 30(5):1041-9. DOI: 10.1046/j.1365-2648.1999.01204.x. View

16.

Sousa V, Rojjanasrirat W . Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2010; 17(2):268-74. DOI: 10.1111/j.1365-2753.2010.01434.x. View

17.

Lampe F, Harding R, Smith C, Phillips A, Johnson M, Sherr L . Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy. J Acquir Immune Defic Syndr. 2010; 54(5):500-5. DOI: 10.1097/QAI.0b013e3181ce6afe. View

18.

Duracinsky M, Lalanne C, Le Coeur S, Herrmann S, Berzins B, Armstrong A . Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument-specific to HIV disease. J Acquir Immune Defic Syndr. 2012; 59(5):506-15. DOI: 10.1097/QAI.0b013e31824be3f2. View

19.

Duracinsky M, Lalanne C, Goujard C, Herrmann S, Cheung-Lung C, Brosseau J . Electronic versus paper-based assessment of health-related quality of life specific to HIV disease: reliability study of the PROQOL-HIV questionnaire. J Med Internet Res. 2014; 16(4):e115. PMC: 4019778. DOI: 10.2196/jmir.3330. View

20.

Holmes W, Ruocco J . Test-retest evaluation of HAT-QoL and SF-36 in an HIV-seropositive sample. AIDS Care. 2008; 20(9):1084-92. DOI: 10.1080/09540120701797437. View